NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells

Circulation Research

Volumn 86, Issue 5, 2000, Pages 514-519

  Lynn, Shugene ^a   Gurr, Jia Ran ^a   Lai, Hsien Tsung ^a   Jan, Kun Yan ^a  

^a ACADEMIA SINICA   (Taiwan)

Author keywords

Arsenite; Atherosclerosis; NADH oxidase; Oxidative DNA damage

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARSENIC TRIOXIDE; CATALASE; DIMETHYL SULFOXIDE; DIPHENYLIODONIUM SALT; DNA; DNA GLYCOSYLTRANSFERASE; MANNITOL; PYRUVIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TIRON;

ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0034677791     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.5.514     Document Type: Article

References (37)

1. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 1990;50:5470-5474.
2. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer. 1992;66:888-892.
3. Falk H, Caldwell GG, Ishak KG, Thomas LB, Popper H. Arsenic-related hepatic angiosarcoma. Am J Ind Med. 1981;2:43-50.
4. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water: multiple risk factors and related malignant neoplasms of Blackfoot disease. Arteriosclerosis. 1988;8:452-460.
5. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, Axelson O. Hypertension and arsenic exposure in Bangladesh. Hypertension. 1999;33:74-78.
6. Hansen ES. International Commission for Protection Against Environmental Mutagens and Carcinogens: ICPEMC Working Paper 7/1/2: shared risk factors for cancer and atherosclerosis: a review of the epidemiological evidence. Mutat Res. 1990;239:163-179.
7. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A. 1973;70:1753-1756.
8. Penn A, Garte SJ, Warren L, Nesta D, Mindich B. Transforming gene in human atherosclerotic plaque DNA. Proc Natl Acad Sci U S A. 1986;83: 7951-7955.
9. Nordenson I, Beckman L. Occupational and environmental risks in and around a smelter in northern Sweden, VII: reanalysis and follow-up of chromosomal aberrations in workers exposed to arsenic. Hereditas. 1982; 96:175-181.
10. Wen WN, Lieu TL, Chang HJ, Wuu SW, Yau ML, Jan KY. Baseline and sodium arsenite-induced sister chromatid exchanges in cultured lymphocytes from patients with Blackfoot disease and healthy persons. Hum Genet. 1981;59:201-203.
11. Wiencke JK, Yager JW, Varkonyi A, Hultner M, Lutze LH. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat Res. 1997;386:335-344.
12. Lynn S, Shiung JN, Gurr JR, Jan KY. Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radic Biol Med. 1998; 24:442-449.
13. Yamanaka K, Hayashi H, Kato K, Hasegawa A, Okada S. Involvement of preferential formation of apurinic/apyrimidinic sites in dimethylarsenic-induced DNA strand breaks and DNA-protein crosslinks in cultured alveolar epithelial cells. Biochem Biophys Res Commun. 1995;207: 244-249.
14. Heydorn K. Environmental variation of arsenic levels in human blood determines by neutron activation analysis. Clin Chim Acta. 1970;28: 349-357.
15. Liu F, Jan KY. DNA damage in arsenite- and cadmium-treated bovine aortic endothelial cells. Free Radic Biol Med. 2000;28:55-63.
16. Van Gelder BF, Slater EC. The extinction coefficient of cytochrome C. Biochim Biophys Acta. 1962;58:593-595.
17. Fukui T, Lassegue B, Kai H, Alexander RW, Griendling KK. Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells. Biochim Biophys Acta. 1995;1231:215-219.
18. Greiber S, Munzel T, Kastner S, Muller B, Schollmeyer P, Pavenstadt H. NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate. Kidney Intl. 1998;53:654-663.
19. Gurr JR, Liu F, Lynn S, Jan KY. Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei. Mutat Res. 1998; 416:137-148.
20. Wang TS, Shu YF, Liu YC, Jan KY, Huang H. Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology. 1997;121: 229-237.
21. Tchou J, Kasai H, Shibutani S, Chung MH, Laval J, Grollman AP, Nishimura S. 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc Natl Acad Sci U S A. 1991;88:4690-4694.
22. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
23. Bhunia AK, Han H, Snowden A, Chatterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem. 1997;272:15642-15649.
24. Lee TC, Ho IC. Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch Toxicol. 1995;69:498-504.
25. Wang TS, Kuo CF, Jan KY, Huang H. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J Cell Physiol. 1996;169:256-268.
26. Casalone R, Granata P, Minelli E, Portentoso P, Giudici A, Righi R, Castelli P, Socrate A, Frigerio B. Cytogenetic analysis reveals clonal proliferation of smooth muscle cells in atherosclerotic plaques. Hum Genet. 1991;87:139-143.
27. Hatzistamou J, Kiaris H, Ergazaki M, Spandidos DA. Loss of heterozygosity and microsatellite instability in human atherosclerotic plaques. Biochem Biophys Res Commun. 1996;225:186-190.
28. Hei TK, Liu SX, Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci U S A. 1998;95:8103-8107.
29. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin: evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem. 1999;274:19814-19822.
30. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-299.
31. Nishio E, Watanabe Y. The involvement of reactive oxygen species and arachidonic acid in alpha 1-adrenoceptor-induced smooth muscle cell proliferation and migration. Br J Pharmacol. 1997;121:665-670.
32. Marumo T, Schini-Kerth VB, Fisslthaler B, Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation. 1997;96:2361-2367.
33. Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest. 1986;77:757-761.
34. Steinberg D. Lewis A. Conner Memorial Lecture: oxidative modification of LDL and atherogenesis. Circulation. 1997;95:1062-1071.
35. Rao GN, Lassegue B, Griendling KK, Alexander RW. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene. 1993;8:2759-2764.
36. Elbirt KK, Whitmarsh AJ, Davis RJ, Bonkovsky HL. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells: role of mitogen-activated protein kinases. J Biol Chem. 1998;273: 8922-8931. (Correction. J Biol Chem. 1998;273:179).
37. Masuya Y, Hioki K, Tokunaga R, Taketani S. Involvement of the tyrosine phosphorylation pathway in induction of human heme oxygenase-1 by hemin, sodium arsenite, and cadmium chloride. J Biochem (Tokyo). 1998;124:628-633.